ETHAN SIM: Open Payments
NPI 1114546488 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 5 payments from 5 companies in 2025. Trend: 2023 $141 · 2024 $432 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| Celgene Corporation | 1 | $30 |
| GENZYME CORPORATION | 1 | $28 |
| ABBVIE INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: BREYANZI, CABLIVI, IMBRUVICA, VONVENDI.
Industry payments across CA — which companies pay providers there.
